Morgan Lewis

Life Sciences Related News

For More Information

Read the Brochure

Life Sciences and Healthcare

Life Sciences Deskbook

New Resource

New Resource: Health Industry Transparency Compliance Resource Center

Emerging Business Tools

visit the Entrepreneur Resource Headquarters

Industry Events


Practice Highlights

Honors

PLCCross-border Quarterly 2012 Life Sciences Legal Market Review

  • Life Sciences Regulatory Super League - Ranked 8th among law firms worldwide

PLCCross-border Life Sciences Handbook 2011/12

  • U.S.:
    • Commercial and Partnering - Highly Recommended
    • Competition/Antitrust - Highly Recommended
    • Corporate - Recommended
    • Government Enforcement and Investigations - Highly Recommended
    • Regulatory - Recommended
    • Regulatory (Medical Devices) - Recommended
  • England: Regulatory - Recommended
  • Japan: Corporate and Commercial - Recommended

Chambers Global 2011: Global Life Sciences - Recommended - Band 3

Chambers USA 2011: National for Life Sciences - Band 3; Washington, D.C. for healthcare/ pharmaceutical/ medical products regulatory - Band 3

UK Legal 500 2010: London: Pharmaceuticals and Biotechnology

Best Lawyers in America 2011: Biotechnology and Healthcare Law Named

BioPharm Insight 2011

  • Ranked 3rd - Global League Table of Legal Advisers on Licensing Agreements - Based upon Volume
  • Ranked 6th - Global League Table of Legal Advisers on Licensing Agreements - Based upon Value
  • Ranked 4th - League Table of Legal Advisers on North American Licensing Agreements - Based upon Volume
  • Ranked 9th - League Table of Legal Advisers on North American Licensing Agreements - Based upon Value
  • Ranked 3rd - League Table of Legal Advisers on European Licensing Agreements - Based upon Volume
  • Ranked 4th - League Table of Legal Advisers on European Licensing Agreements - Based upon Value
  • Ranked 2nd - League Table of Legal Advisers on Asia-Pacific Licensing Agreements - Based upon Volume
  • Ranked 5th - League Table of Legal Advisers on Asia-Pacific Licensing Agreements - Based upon Value
U.S. News & World Report/Best Lawyers 2010: Ranked Tier 1 National Practice - Biotechnology

Clients

16 of the top 20 pharmaceutical companies

7 of the top 20 biotechnology companies

9 of the top 20 medical device companies

Related Events

06/06/12-06/08/12 ABA’s Civil False Claims Act and Qui Tam Enforcement 2012
Katie McDermott, presenter, "Investigation of a False Claims Act Case"
06/06/12-06/07/12 2012 Health Law Institute in Minneapolis
Arianne Callender, speaker, "Fraud and Abuse Update"
06/09/12-06/12/12 The Business of Medicine 2012 San Diego Summit
Kathleen McDermott, presenter, "Shining a Light on the Sunshine Act: What You Need To Know"
View all events

Related News

05/04/12 Regulatory Policy: CBER Importance Boosted With Attention To Biologic Drugs, Biosimilars, Speakers Say
Life Sciences and Healthcare partner Stephen Paul Mahinka is quoted.
04/25/12 Q&A With Morgan Lewis' Randall Sunberg, Law360
Business and Finance partner Randall Sunberg is interviewed as part of Law360 's Q&A series.
04/05/12 Biosimilars Naming and Labeling: An FDLI Dialogue, Update Magazine
Life Sciences and Healthcare partner Stephen Paul Mahinka is quoted.
View all news

Related Publications

05/22/12 Manufacturer Patient Support Initiatives: Current Practices and Recent Challenges, presented at the AHLA/FDLI's Intersecting Worlds of Drug, Device, Biologics and Health Law
05/09/12 Eleventh Circuit Rejects FTC Challenge to Reverse Payment Settlement
Decision by court of appeals affirms that settlements that do not expand the exclusionary scope of a patent are not subject to antitrust challenge.
05/03/12 HHS Plugs Payment Suspensions as Key Tool in Latest Takedown
The Medicare Fraud Strike Force's use of a pivotal ACA regulation to suspend payments during criminal investigations signals a turning point in its prosecution strategy.
View all publications
37 news articles found
page 2 of 2
Jul 11, 2006 - ABA Intellectual Property Law Section’s Resolution 413-1

On June 22, 2006 the Intellectual Property (IP) Law Section of the American Bar Association (ABA) held its summer meeting in Boston. Resolution 413-1, entitled State Prescription Drug Compulsory Licensing was presented, debated, and overwhelmingly passed.

Mar 29, 2006 - Morgan Lewis to Exhibit at BIO 2006

Morgan Lewis sponsors BIO 2006, the world's largest gathering of biotechnology leaders.

Dec 13, 2005 - Morgan Lewis’ Life Sciences Practice Recommended in PLC Cross-border Life Sciences Handbook

Morgan Lewis is pleased to announce that Practical Law Company recommends the firm’s Life Sciences Practice and its attorneys in the PLCCross-border Life Sciences Handbook 2005/06.

Sep 28, 2005 - Morgan Lewis Announces New Joint Venture with TMI Associates, The Sixth Largest Law Firm in Japan

Morgan Lewis & Bockius LLP, a global law firm, today announced a new joint venture with TMI Associates, one of the top law firms in Japan, effective immediately. The new partnership, named Morgan Lewis-TMI, will focus primarily on cross-border corpora

Feb 09, 2004 - Morgan Lewis Expands Life Science Practice Capabilities
Oct 06, 2003 - Former Pharmacia General Counsel Richard T. Collier Joins Morgan Lewis
Dec 02, 2002 - Morgan Lewis Represents Enzon in $360 Million Purchase of Abelcet® North American Business From Elan
Apr 09, 2002 - Morgan Lewis London Partner Named Leading Life Sciences Lawyer
Jun 11, 2001 - Morgan Lewis Opens Northern Virginia Office and Extends Reach of Global Technology Practice
page 2 of 2